Artwork

Content provided by Mayo Clinic Laboratories. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mayo Clinic Laboratories or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Updates Streamline Autoimmune Neurology Testing: Anastasia Zekeridou, M.D., Ph.D.

16:55
 
Share
 

Manage episode 422967997 series 2908385
Content provided by Mayo Clinic Laboratories. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mayo Clinic Laboratories or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Anastasia Zekeridou, M.D., Ph.D., explains how Mayo Clinic Laboratories' updated panels and methodology boost the accuracy and efficiency of testing for three autoimmune neurology biomarkers. Early diagnosis is key to managing debilitating conditions associated with these antibodies.

(00:32)
Could you please give our listeners an overview of your role at Mayo Clinic?

(01:22)
What updates are happening in our laboratory to increase specificity when we receive a patient's serum and CSF for most of the CNS evaluations?

(03:48)
Why are these updates and additions important in the larger disease state?

(06:16)
Could you expound upon the relationship between the clinical practice and the lab?

(08:32)
What do these changes mean for patient care?

(10:27)
What about the inclusion of AMPA in the pediatric evaluation, and the inclusion of IgLON5 with autoimmune axonal?

(12:58)
How does your lab discern when it's time to add a biomarker?

(15:44)
What are you most excited about?

  continue reading

309 episodes

Artwork
iconShare
 
Manage episode 422967997 series 2908385
Content provided by Mayo Clinic Laboratories. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mayo Clinic Laboratories or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Anastasia Zekeridou, M.D., Ph.D., explains how Mayo Clinic Laboratories' updated panels and methodology boost the accuracy and efficiency of testing for three autoimmune neurology biomarkers. Early diagnosis is key to managing debilitating conditions associated with these antibodies.

(00:32)
Could you please give our listeners an overview of your role at Mayo Clinic?

(01:22)
What updates are happening in our laboratory to increase specificity when we receive a patient's serum and CSF for most of the CNS evaluations?

(03:48)
Why are these updates and additions important in the larger disease state?

(06:16)
Could you expound upon the relationship between the clinical practice and the lab?

(08:32)
What do these changes mean for patient care?

(10:27)
What about the inclusion of AMPA in the pediatric evaluation, and the inclusion of IgLON5 with autoimmune axonal?

(12:58)
How does your lab discern when it's time to add a biomarker?

(15:44)
What are you most excited about?

  continue reading

309 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide